Insertion problems, removal problems, and contraception failures with Implanon®;Implanon®: Difficultés d'insertion et de retrait, ́echecs contraceptifs

Gynecologie Obstetrique et Fertilite

Volumn 33, Issue 12, 2005, Pages 986-990

  Bensouda Grimaldi, L ^a   Jonville Bera A P ^a   Beau Salinas, F ^a   Llabres, S ^b   Autret Leca, E ^a  

^a CHU BRETONNEAU   (France)

^b Laboratoire Akzo Nobel Organon   (France)

Author keywords

Contraception; Etonogestrel; Implanon ; Insertion problems; Migration; Pregnancy; Removal problems

Indexed keywords

ETONOGESTREL; 3 KETO DESOGESTREL; 3-KETO-DESOGESTREL; CONTRACEPTIVE AGENT; DESOGESTREL;

CONTRACEPTION; DEVICE REMOVAL; DRUG SURVEILLANCE PROGRAM; ERROR; FEMALE; HUMAN; MENSTRUAL CYCLE; PREGNANCY RATE; REVIEW; SIDE EFFECT; TREATMENT FAILURE; UNWANTED PREGNANCY; ADULT; ARTICLE; DRUG IMPLANT; FOREIGN BODY; METHODOLOGY; POSTMARKETING SURVEILLANCE; PREGNANCY; STATISTICS; TIME;

ADULT; CONTRACEPTION; CONTRACEPTIVE AGENTS, FEMALE; DESOGESTREL; DEVICE REMOVAL; DRUG IMPLANTS; FEMALE; FOREIGN-BODY MIGRATION; HUMANS; PREGNANCY; PREGNANCY, UNWANTED; PRODUCT SURVEILLANCE, POSTMARKETING; TIME FACTORS;

EID: 29244457209     PISSN: 12979589     EISSN: 17696682     Source Type: Journal    
DOI: 10.1016/j.gyobfe.2005.10.016     Document Type: Article

References (13)

1. J. Le, and C. Tsourounis Implanon: a critical review Ann. Pharmacother. 35 2001 329 336
2. V. Brache, A. Faundes, F. Alvarez, and L. Cochon Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials Contraception 65 2002 63 74
3. G.S. Merki-Feld, C. Bredenfeld, B. Migge, and P.J. Keller Nonpalpable ultrasonographically not detectable Implanon® rods can be localized by magnetic resonance imaging Contraception 61 2001 325 328
4. F. Sergent, C. Clamageran, A.M. Bastard, E. Verspyck, and L. Marpeau Acceptabilit́ de l'implant contraceptif ̀ l'etonogestrel (Implanon®) J. Gynecol. Obstet. Biol. Reprod. (Paris) 33 2004 407 415
5. Décret du 24 mai 1984 (JO du 30/5/1984) Livre V du Code de la Santé publique (articles R5144-1 et R5144-11). Décret 95/278 du 13 mars 1995. Décret 95-566 du 6 mai 1995.
6. M.L. Martinez-Frias, E. Rodriguez-Pinilla, E. Bermejo, and L. Prieto Prenatal exposure to sex hormones: a case-control study Teratology 75 1998 8 12
7. L. Raman-Wilms, A. Lin-in Tseng, S. Wighardt, T.R. Einarson, and G. Koren Fetal genital effects of first-trimester sex hormone exposure: a meta-analysis Obstet. Gynecol. 85 1995 141 149
8. A. Glasier Implantable contraceptives for women: effectiveness, discontinuation rates, return of fertility, and outcome of pregnancies Contraception 65 2002 29 37
9. S.R. Zheng, H.M. Zheng, S.Z. Qian, G.W. Sang, and R.F. Kapper A randomized multicenter study comparing the efficacy and bleeding pattern of a single rod (Implanon®) and a six-capsule (Norplant®) hormonal contraceptive Implant Contraception 60 1999 1 8
10. H.B. Croxatto, J. Urbancsek, R. Massai, and H. Coelingh Bennink Van Beek A and the implanon® Study Group. A multicentre efficacy and safety study of the single contraceptive implant Implanon® Hum. Reprod. 14 1999 976 981
11. L. Mascarenhas Insertion and removal of Implanon Contraception 58 1998 79 83
12. L. Mascarenhas Insertion and removal of Implanon: practical considerations Eur. J. Contracept. Reprod. Health Care 5 suppl 2 2000 29 34
13. S.R. Zheng, H.M. Zheng, S.Z. Qian, G.W. Sang, and R.F. Kapper A long term study of the efficacy and acceptability of a single-rod hormonal contraceptive implant (Implanon®) in healthy women in China Eur. J. Contracept. Reprod. Health Care 4 1999 85 93